Fig. 2.
A: Boxplot of DRS of patients in different molecular subtypes. Patients were stratified into groups of Luminal A, Luminal B, HER2 and Basal like by the ER, PR and HER2 markers. B: Boxplot of DRS between doxorubicin-resistant cells (High IC50) and doxorubicin-sensitive (Low IC50) cells. C: Enrichment analysis heatmap plot of those significant SNPs’ epigenetic annotation. Enrichment score (ES) are color-coded from light to dark.